Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

SHE:000766 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,326	1,322	1,470	1,470	1,514	1,111
Other Revenue	0.5	0.5	3.57	0.58	1.32	0.72
Revenue	1,326	1,323	1,473	1,471	1,515	1,112
Revenue Growth (YoY)	-9.18%	-10.23%	0.18%	-2.95%	36.31%	-43.77%
Cost of Revenue	334.07	329.03	381.17	352.93	350.18	229.94
Gross Profit	992.2	993.53	1,092	1,118	1,165	881.86
Selling, General & Admin	772.19	789.26	905	923.47	986.24	1,042
Research & Development	53.18	50.34	45.82	64.91	63.52	50.33
Other Operating Expenses	15.07	9.88	10.62	5.52	5.4	3.96
Operating Expenses	844.23	853.14	970.43	990.81	1,052	1,228
Operating Income	147.97	140.39	121.75	127.01	113.33	-346.24
Interest Expense	-86	-84.98	-83.15	-88.79	-97.19	-125.27
Interest & Investment Income	3.72	5.28	4.02	11.5	26.36	23.31
Other Non Operating Income (Expenses)	-5.32	-2.66	1.23	-3.64	3.47	-0.37
EBT Excluding Unusual Items	60.37	58.03	43.85	46.08	45.98	-448.58
Gain (Loss) on Sale of Investments	-0.46	0.03	-2.61	-0.05	-0.01	-
Gain (Loss) on Sale of Assets	-0.17	-0.17	-0.21	-0.02	0.83	57.58
Asset Writedown	-0.13	-0.12	0.22	-0.11	-1.49	-0.43
Other Unusual Items	11.03	9.32	13.61	4.28	14.32	35.6
Pretax Income	70.64	67.09	54.86	50.17	59.62	-355.83
Income Tax Expense	12.25	11.11	11.63	20.99	25.64	4.83
Earnings From Continuing Operations	58.38	55.98	43.23	29.19	33.99	-360.66
Minority Interest in Earnings	0.45	0.46	0.71	0.96	1.29	1.16
Net Income	58.83	56.44	43.93	30.15	35.27	-359.5
Net Income to Common	58.83	56.44	43.93	30.15	35.27	-359.5
Net Income Growth	27.46%	28.46%	45.71%	-14.52%	-	-
Shares Outstanding (Basic)	940	941	879	1,005	882	972
Shares Outstanding (Diluted)	940	941	879	1,005	882	972
Shares Change (YoY)	7.00%	7.05%	-12.57%	13.97%	-9.24%	0.40%
EPS (Basic)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS (Diluted)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS Growth	19.12%	20.00%	66.67%	-25.00%	-	-
Free Cash Flow	165.94	113.58	86.11	174.42	112.85	61.55
Free Cash Flow Per Share	0.18	0.12	0.10	0.17	0.13	0.06
Gross Margin	74.81%	75.12%	74.13%	76.00%	76.89%	79.32%
Operating Margin	11.16%	10.62%	8.26%	8.64%	7.48%	-31.14%
Profit Margin	4.44%	4.27%	2.98%	2.05%	2.33%	-32.34%
Free Cash Flow Margin	12.51%	8.59%	5.85%	11.86%	7.45%	5.54%
EBITDA	209.82	204.82	196.49	198.19	182.72	-278.53
EBITDA Margin	15.82%	15.49%	13.34%	13.48%	12.06%	-25.05%
D&A For EBITDA	61.85	64.42	74.74	71.18	69.39	67.71
EBIT	147.97	140.39	121.75	127.01	113.33	-346.24
EBIT Margin	11.16%	10.62%	8.26%	8.64%	7.48%	-31.14%
Effective Tax Rate	17.35%	16.56%	21.20%	41.83%	42.99%	-
Revenue as Reported	1,326	1,323	1,473	1,471	1,515	1,112
Advertising Expenses	-	249.73	352.83	298.68	375.06	299.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.